Skip to Content
Merck
CN
Search Within
Topic
Content Type
Collections
Topic Area
Product Category
Applications

6342-70-7

Applied Filters:
Keyword:'6342-70-7'
Showing 1-10 of 828 results for "6342-70-7" within Site Content
Determination of 7 Nitrosamines in Drinking Water
Nitrosamines analysis by solid phase extraction (SPE) and subsequent gas chromatography-tandem mass spectrometry (GC-MS/MS) according to GB 5750.10-2023.
Color Determination of Sugar based on ICUMSA Color GS1-7
Learn about the ICUMSA® method GS1-7 to measure the color of sample solutions of raw sugar, brown sugar, or sugar syrups.
Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China
Merck is expanding production capacity for highly purified reagents with a € 70 million investment at Nantong, China manufacturing site.
Merck Invests €70 million to Expand ADC Manufacturing for Novel Cancer Therapies
Merck today announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri, USA.
Concentrating Large Volumes With Centricon® Plus-70 Centrifugal Filter Device
Large-volume centrifugal filter devices are a convenient alternative to stirred cell ultrafiltration devices for purifying proteins from large volumes of solution.
X-tremeGENE™ 9 DNA Transfection Reagent Protocol
Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).
X-tremeGENE™ HP DNA Transfection Reagent Protocol
Cell preparation for transfection Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).
Estimation of Proline in Fruit and Vegetable Juices
Spectrophotometric determination of proline by the Ninhydrin method, per EN 1141 and German Food and Feed Code §64 LFBG 31.00-7.
QuEChERS Method for Pesticide Residue Analysis
QuEChERS method for pesticide residue analysis requires only small quantities of solvent and is capable of generating recoveries of 70-120% with RSDs <5% for a wide range of compounds.
RNA Therapeutics & Delivery USA
Visit us at booth #7 to learn about our solutions to help you overcome your mRNA manufacturing and LNP formulation challenges.
Page 1 of 83